Lars Stöckl

USPTO Granted Patents = 6 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

Airway Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391956 - Methods, compositions and cells for preparing surfactant protein D (SP-D) (2025-08-19),

2. 10975389 - Methods and compositions for preparing surfactant protein D (SP-D) (2021-04-13),

3. 10752914 - Methods, compositions and cells for preparing surfactant protein D (SP-D) (2020-08-25),

4. 9527899 - Recombinant human follicle-stimulating hormone (2016-12-27),

5. 9051356 - Use of human cells of myeloid leukaemia origin for expression of antibodies (2015-06-09),

6. 8846344 - Process for the purification of glycoproteins (2014-09-30),

Title: The Innovative Contributions of Lars Stöckl

Introduction

Lars Stöckl, a distinguished inventor based in Berlin, Germany, has made notable strides in the field of biotechnology. With a portfolio of four patents, he has contributed significantly to the development of methods and compositions relating to surfactant proteins, which hold potential implications in various medical and therapeutic applications.

Latest Patents

Among his latest patents, Lars Stöckl has focused on innovative approaches for the preparation of surfactant protein D (SP-D). His patents outline methods that include the expression of human SP-D in specific cell lines and its subsequent purification. In particular, his work emphasizes the preparation of oligomeric forms of human SP-D, showcasing his commitment to advancing research in this area.

Career Highlights

Lars Stöckl has been associated with prominent companies such as Glycotope GmbH and Airway Therapeutics, Inc., where he has honed his expertise in the biotechnology sector. His career is marked by a consistent drive towards innovation, leading to developments that bridge laboratory research and practical applications.

Collaborations

Throughout his journey, Lars has collaborated with esteemed colleagues, including Steffen Goletz and Jan Susan Rosenbaum. These partnerships have played a crucial role in enriching his research and expanding the reach of his innovations within the scientific community.

Conclusion

In summary, Lars Stöckl's contributions to the field of biotechnology through his patents and collaborations underscore his status as an influential inventor in Berlin. His work on surfactant protein D not only reflects his innovative spirit but also paves the way for advancements that could benefit medical research and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.